Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Generic for quillivant?Generic name for buspar?Spravato sales revenue 2025 2026 janssen?Street price of adderall 15mg xr?Biktarvy hiv medication?
See the DrugPatentWatch profile for Stiolto
Stiolto is a chronic obstructive pulmonary disease (COPD) inhaler that contains two active ingredients: tiotropium and olodaterol. [1]
Tiotropium is a long-acting antimuscarinic (LAMA). It helps relax the airway muscles by blocking muscarinic receptors, which can reduce bronchoconstriction. [1] Olodaterol is a long-acting beta2-agonist (LABA). It relaxes airway smooth muscle by stimulating beta2 receptors. [1]
Stiolto combines a LAMA (tiotropium) and a LABA (olodaterol) to provide bronchodilation through two different mechanisms, aimed at improving airflow and helping manage COPD symptoms. [1]
Yes. Many COPD inhalers use one long-acting bronchodilator (either LAMA or LABA) or different combinations. The defining feature of Stiolto is that it specifically pairs tiotropium + olodaterol. [1]
[1] https://www.drugs.com/stiolto.html
Other Questions About Stiolto :